SCHEMBL7987076

SCHEMBL7987076

CCC(=O)Nc1ccc2c(c1)ncn2-c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 7/20 1.00
SMN1; SMN2 Q16637 6/20 1.00
NPC1 O15118 6/20 1.00
LMNA P02545 1/20 1.00
HPGD P15428 3/20 0.75
KMT2A Q03164 3/20 0.73
MEN1 O00255 2/20 0.73
ALDH1A1 P00352 3/20 0.63
TP53 P04637 1/20 0.63
HSD17B10 Q99714 1/20 0.63
FGFR1 P11362 8/20 0.61
KDM4E B2RXH2 2/20 0.54
MAPT P10636 1/20 0.54
MAPK1 P28482 1/20 0.54
HTT P42858 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
GAA P10253 1/20 0.53
GFER P55789 1/20 0.53
AKR1C3 P42330 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7990425 0.99 RAB9A (0.98) RAB9ASMN1; SMN2NPC1LMNAHPGD
SCHEMBL13305038 0.87 RAB9A (0.77) RAB9ASMN1; SMN2NPC1LMNAHPGD
SCHEMBL7989436 0.86 NPC1 (1.00) RAB9ASMN1; SMN2NPC1LMNAHPGD
Hydrochloric Acid SCHEMBL7976246 0.85 NPC1 (0.97) RAB9ASMN1; SMN2NPC1LMNAHPGD
SCHEMBL7986579 0.80 RAB9A (0.71) RAB9ASMN1; SMN2NPC1LMNAHPGD
SCHEMBL23657668 0.78 NPC1 (0.69) RAB9ASMN1; SMN2NPC1LMNAHPGD
SCHEMBL13305064 0.77 RAB9A (0.67) RAB9ASMN1; SMN2NPC1LMNAHPGD
SCHEMBL7021239 0.76 LCK (0.67) RAB9ASMN1; SMN2NPC1LMNAHPGD
SCHEMBL28566503 0.76 SMN1; SMN2 (0.62) RAB9ASMN1; SMN2NPC1LMNAHPGD
SCHEMBL7989417 0.76 FGFR1 (1.00) RAB9ASMN1; SMN2NPC1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218388-B1 THERAPY OF PROTEIN TYROSINE KINASE MEDIATED CANCER, ATHEROSCLEROSIS, RESTENOSIS, AND PSORIASIS BY ADMINISTERING BENZIMIDAZOLE DERIVATIVE WARNER-LAMBERT COMPANY 2001-04-17 US disclosed
US-5990146-A TREATING PROTEIN TYROSINE KINASE MEDIATED CANCER; ANTICARCINOGENIC AGENTS; ATHEROSCLEROSIS; RESTENOSIS; PSORIASIS; ANTIPROLIFERATIVE AGENTS WARNER-LAMBERT COMPANY (US) 1999-11-23 US disclosed